This article was originally published in The Gray Sheet
Executive SummaryReduces outstanding indebtedness using $43 mil. in net proceeds from its initial public offering of 6 mil. shares of common stock at $8 per share. The firm issued 5.75 mil. shares; stockholders issued the remaining 250,000. Alex. Brown & Sons; Donaldson, Lufkin and Jenrette; and Robertson, Stephens managed the underwriting of the offering. The firm initially offered 10 mil. shares for sales at a price of $12.50 per share ("The Gray Sheet" Feb. 15, p. 12); shareholders were offering 1.2 mil. shares.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.